Public Health

Disease outbreaks, vaccines, hospital and health-system news, medical research and guidance from health authorities.

Latest Public Health stories

Tai Chi, Mindfulness May Help With Pain and Fatigue Following Cancer Treatment
health

Tai Chi, Mindfulness May Help With Pain and Fatigue Following Cancer Treatment

Mindfulness-based cancer recovery and Tai Chi/Qigong improve fatigue and pain interference in patients with post-cancer treatment distress.

Cancer Therapy Advisor•
Sep 24, 2026
Numbing Creams, Breastfeeding, and Faster Shots Top New Guideline to Ease Needle Pain and Fear at Every Age
health

Numbing Creams, Breastfeeding, and Faster Shots Top New Guideline to Ease Needle Pain and Fear at Every Age

A new guideline lists 16 evidence-based ways to ease vaccine pain and fear, from breastfeeding babies to numbing creams. What families can use.

Medical Daily•
Sep 24, 2026
Orange County man dies after contracting West Nile virus, family says
health

Orange County man dies after contracting West Nile virus, family says

The family of an Orange County man says he died after contracting West Nile virus and is sharing his story in hopes of warning others.

ABC7 Los Angeles•
Sep 24, 2026
Cancer Horoscope Today: September 24, 2026
entertainment

Cancer Horoscope Today: September 24, 2026

See what the stars have in store for your sign

Vogue India•
Sep 24, 2026
Single-nucleus atlas of cell-type specific genetic regulation in the human brain
health

Single-nucleus atlas of cell-type specific genetic regulation in the human brain

Genetic risk variants for common diseases are predominantly located in non-coding regulatory regions and modulate gene expression. Although bulk tissue studies have elucidated shared mechanisms of regulatory and disease-associated genetics, the cellular specificity of these mechanisms remains largely unexplored. Here we present a comprehensive, single-nucleus multi-ancestry atlas of genetic regulation of gene expression in the human prefrontal cortex, comprising 5.6 million nuclei from 1,384 don

Nature•
Sep 24, 2026
Cheaper Cancer Drug Alternatives Slash Treatment Costs
health

Cheaper Cancer Drug Alternatives Slash Treatment Costs

Key takeawaysThe high cost of biologic drugs for cancer treatment can add to the financial burden of healthcare; lower-cost versions known as

Mirage News•
Sep 24, 2026
Vancouver biotech Zymeworks closes US$929M Theravance deal
health

Vancouver biotech Zymeworks closes US$929M Theravance deal

Theravance deal diversifies Zymeworks’ portfolio beyond cancer-focused business

Richmond News•
Sep 24, 2026

'My children shouldn't have to do this': Sons' epic walk for terminally ill dad

Two sons are preparing to walk hundreds of miles across the country in a desperate bid to help their terminally ill dad access potentially life-extending cancer treatment.

Bournemouth Echo•
Sep 24, 2026
Global Nanomedicine Market to Reach USD 581.2 Bn. by 2034, Driven by Rising Chronic Disease Prevalence, Expanding Nanotechnology-Based Drug Delivery, and Advances in Precision Diagnostics and Therapeutics Says Maximize Market Research
health

Global Nanomedicine Market to Reach USD 581.2 Bn. by 2034, Driven by Rising Chronic Disease Prevalence, Expanding Nanotechnology-Based Drug Delivery, and Advances in Precision Diagnostics and Therapeutics Says Maximize Market Research

PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Nanomedicine Market was valued at USD 207.91 Billion in 2025 and is projected to expand at a 12.1% CAGR from 2025 to 2034, reaching USD 581.2 Billion by 2034, according to a new analysis by Maximize Market Research. Global...

Pr Newswire Uk•
Sep 24, 2026
Octant Announces First Patient Dosed in Phase 1b/2 Clinical Study of OCT-980 for the Treatment of Retinitis Pigmentosa
health

Octant Announces First Patient Dosed in Phase 1b/2 Clinical Study of OCT-980 for the Treatment of Retinitis Pigmentosa

EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc., a clinical-stage drug discovery company developing corrector therapies for protein misfolding diseases, today announced that the first patient has been dosed in its ongoing Phase 1/2 clinical study evaluating OCT-980, an investigational oral small molecule for the treatment of rhodopsin-associated autosomal dominant Retinitis Pigmentosa (RHO-adRP). RHO-adRP is an inherited retinal disease caused by mutations in the RHO gene, the most common for

Businesswire•
Sep 24, 2026
What are my children exposed to? Why I want testing for cancer-causing chemicals
science

What are my children exposed to? Why I want testing for cancer-causing chemicals

People living near a lagoon branded "a shame on Britain" want to be tested for cancer-causing PCBs.

The Bbc•
Sep 24, 2026
Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research
health

Global Multiple Sclerosis Treatment Market to Grow at 5.8% CAGR, Reaching USD 44.45 Billion by 2034 as Advanced Therapies and Disease-Modifying Treatments Gain Momentum, Says Maximize Market Research

PUNE, India, Sept. 24, 2026 /PRNewswire/ -- The Global Multiple Sclerosis Treatment Market was valued at USD 26.76 Billion in 2025 and is projected to expand at a 5.8% CAGR from 2026 to 2034, reaching USD 44.45 Billion by 2034, according to a new analysis by Maximize Market Research....

Pr Newswire•
Sep 24, 2026

Wyden Says Klomp, Under Pressure, Restarted VFC COVID Shot Access

Body: Senate Finance Committee ranking Democrat Ron Wyden (WI) took credit for HHS deputy secretary nominee Chris Klomp restarting access to COVID-19 vaccines through the Vaccines for Children program, suggesting Klomp only did so under pressure from Wyden and his staff to resolve the issue. The Centers for Disease Control and Prevention program, which provides vaccines for low-income children, was not providing COVID shots until Wednesday (Sept. 23). Despite stating Klomp had apparently resolve

Insidehealthpolicy•
Sep 24, 2026
CDC lists first U.S. measles death of 2026 on website, while Pennsylvania reports four deaths
health

CDC lists first U.S. measles death of 2026 on website, while Pennsylvania reports four deaths

The Centers for Disease Control and Prevention updated its website to note a single death from the measles so far this year, but officials in Pennsylvania have announced four measles deaths.

The Washington Times•
Sep 24, 2026
Oklahoma doctors highlight progress in childhood cancer treatment
health

Oklahoma doctors highlight progress in childhood cancer treatment

During Childhood Cancer Awareness Month, experts at the Jimmy Everest Center in Oklahoma are sharing how research is improving outcomes for young cancer patients, including a near 100% cure rate for certain leukemia cases.

Koco News Channel Five•
Sep 24, 2026
Maine’s first new hospital in 30 years opens in Bangor
health

Maine’s first new hospital in 30 years opens in Bangor

Encompass Health Rehabilitation Hospital of Bangor is located at 1017 Union St. in Bangor.

Wabi•
Sep 24, 2026
The U.S. May Be Approaching a Measles Crisis, and Some Babies Face Risks Before Birth
science

The U.S. May Be Approaching a Measles Crisis, and Some Babies Face Risks Before Birth

Learn more about the recent rise in measles cases and how the virus is especially dangerous for newborns.

Discover Magazine•
Sep 24, 2026
Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics
science

Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics

Researchers captured the first high-resolution 3D images of the muscle cell calcium channel RyR1 at six stages of opening inside the intact sarcoplasmic reticulum membrane, potentially helping to explain mechanisms behind certain muscle diseases. The post Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics appeared first on GEN - Genetic Engineering and Biotechnology News .

Gen•
Sep 24, 2026
KYTX Stock Reverses Gains After One-Year Cell Therapy Trial Data — But CEO Says Disease Burden Justifies A Premium Price
business

KYTX Stock Reverses Gains After One-Year Cell Therapy Trial Data — But CEO Says Disease Burden Justifies A Premium Price

Chief executive Warner Biddle said the therapy’s durability “exceeded even our expectations.”

Asianet Newsable•
Sep 24, 2026
FDA panel backs GRAIL’s Galleri multi-cancer detection test
health

FDA panel backs GRAIL’s Galleri multi-cancer detection test

The FDA is not bound by the panel’s recommendations and will make the final regulatory decision

Indianpharmapost•
Sep 24, 2026

How Info60 covers this topic

Each story below is a short excerpt from reporting by an established publisher, shown in the publisher's own words. We credit the publisher and link to the original article. Stories are matched to this topic by keyword and shown newest first.

Related topics